These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 24476502

  • 1. PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.
    Stoica BA, Loane DJ, Zhao Z, Kabadi SV, Hanscom M, Byrnes KR, Faden AI.
    J Neurotrauma; 2014 Apr 15; 31(8):758-72. PubMed ID: 24476502
    [Abstract] [Full Text] [Related]

  • 2. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
    Tao X, Chen X, Hao S, Hou Z, Lu T, Sun M, Liu B.
    Neuroscience; 2015 Apr 16; 291():26-36. PubMed ID: 25668593
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat.
    Besson VC, Zsengellér Z, Plotkine M, Szabó C, Marchand-Verrecchia C.
    Brain Res; 2005 Apr 18; 1041(2):149-56. PubMed ID: 15829224
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.
    Kabadi SV, Stoica BA, Byrnes KR, Hanscom M, Loane DJ, Faden AI.
    J Cereb Blood Flow Metab; 2012 Jan 18; 32(1):137-49. PubMed ID: 21829212
    [Abstract] [Full Text] [Related]

  • 9. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Aug 18; 310(2):425-36. PubMed ID: 15075382
    [Abstract] [Full Text] [Related]

  • 10. PARP inhibition attenuates early brain injury through NF-κB/MMP-9 pathway in a rat model of subarachnoid hemorrhage.
    Chen T, Wang W, Li JR, Xu HZ, Peng YC, Fan LF, Yan F, Gu C, Wang L, Chen G.
    Brain Res; 2016 Aug 01; 1644():32-8. PubMed ID: 27157545
    [Abstract] [Full Text] [Related]

  • 11. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.
    Hilton GD, Stoica BA, Byrnes KR, Faden AI.
    J Cereb Blood Flow Metab; 2008 Nov 01; 28(11):1845-59. PubMed ID: 18612315
    [Abstract] [Full Text] [Related]

  • 12. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation.
    Wani WY, Sunkaria A, Sharma DR, Kandimalla RJ, Kaushal A, Gerace E, Chiarugi A, Gill KD.
    Neuroscience; 2014 Jan 31; 258():1-15. PubMed ID: 24231740
    [Abstract] [Full Text] [Related]

  • 13. Prevention of traumatic brain injury-induced neuron death by intranasal delivery of nicotinamide adenine dinucleotide.
    Won SJ, Choi BY, Yoo BH, Sohn M, Ying W, Swanson RA, Suh SW.
    J Neurotrauma; 2012 May 01; 29(7):1401-9. PubMed ID: 22352983
    [Abstract] [Full Text] [Related]

  • 14. Microglial activation induced by the alarmin S100B is regulated by poly(ADP-ribose) polymerase-1.
    Xu J, Wang H, Won SJ, Basu J, Kapfhamer D, Swanson RA.
    Glia; 2016 Nov 01; 64(11):1869-78. PubMed ID: 27444121
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabó C, Endres M.
    Int J Mol Med; 2001 Mar 01; 7(3):255-60. PubMed ID: 11179503
    [Abstract] [Full Text] [Related]

  • 16. Propofol limits microglial activation after experimental brain trauma through inhibition of nicotinamide adenine dinucleotide phosphate oxidase.
    Luo T, Wu J, Kabadi SV, Sabirzhanov B, Guanciale K, Hanscom M, Faden J, Cardiff K, Bengson CJ, Faden AI.
    Anesthesiology; 2013 Dec 01; 119(6):1370-88. PubMed ID: 24121215
    [Abstract] [Full Text] [Related]

  • 17. Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.
    Besson VC.
    Br J Pharmacol; 2009 Jul 01; 157(5):695-704. PubMed ID: 19371326
    [Abstract] [Full Text] [Related]

  • 18. The role of PARP activation in glutamate-induced necroptosis in HT-22 cells.
    Xu X, Chua CC, Zhang M, Geng D, Liu CF, Hamdy RC, Chua BH.
    Brain Res; 2010 Jul 09; 1343():206-12. PubMed ID: 20451505
    [Abstract] [Full Text] [Related]

  • 19. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury.
    Piao CS, Loane DJ, Stoica BA, Li S, Hanscom M, Cabatbat R, Blomgren K, Faden AI.
    Neurobiol Dis; 2012 Jun 09; 46(3):745-58. PubMed ID: 22426396
    [Abstract] [Full Text] [Related]

  • 20. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion.
    Hamby AM, Suh SW, Kauppinen TM, Swanson RA.
    Stroke; 2007 Feb 09; 38(2 Suppl):632-6. PubMed ID: 17261705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.